FDMT 4D Molecular Therapeutics, Inc. logo

FDMT 4D Molecular Therapeutics, Inc.

Healthcare
$8.76+0.00%OpenMarket Cap: $457.9M

As of 2026-05-26

Insider Statistics (Q1 2026)

Acquisitions

6

Dispositions

4

Buy/Sell Ratio

1.50

Net Shares

+1,230,610

Shares Acquired

1,232,086

Shares Disposed

1,476

Total Bought ($)

$0.00

Total Sold ($)

$2.00

Recent Insider Trades
Filing DateNameTypeActionSharesPriceShares After
Fri Mar 27Simms Christopher Paulofficer: See RemarksSell219,000$9.88219,000
Fri Mar 27Kirn Daviddirector, officer: Chief Executive OfficerSell750,000$9.88750,000
Fri Mar 27Bizily Scottofficer: Chief Legal OfficerSell217,000$9.88217,000
Tue Mar 24Gupta Ashooofficer: VP, Finance and ControllerSell310$8.6146,914
Tue Mar 24Gupta Ashooofficer: VP, Finance and ControllerSell80$8.6147,055
Tue Mar 24Gupta Ashooofficer: VP, Finance and ControllerSell865$0.0047,224
Tue Mar 24Gupta Ashooofficer: VP, Finance and ControllerSell221$0.0047,135
Wed Jan 07SBLENDORIO GLENNdirectorSell45,000$7.3045,000
Wed Jan 07SBLENDORIO GLENNdirectorSell11,250$2.760
Tue Dec 23Gupta Ashooofficer: VP, Finance and ControllerSell866$0.0046,528
Tue Dec 23Gupta Ashooofficer: VP, Finance and ControllerSell220$0.0046,438